Arrowhead Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report3 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Arrowhead Pharmaceuticals, Inc.
59.54
−0.03 · −0.05%
post 59.54 0.00%
Expected move
Inputs8Q avg ±9.3%·×0.95·fair
straddle ±14.9%
spot 59.53exp Dec 18ATM strike 60ATM straddle 10.45IV 63%
−2.99%
vs ±8.5% implied · ×0.35
shaded = implied · ▲▼ = realized
Linked news
−6.18%
shares held · 10 largest managers
1.07%
ARWR weight · XBI
Arrowhead Pharmaceuticals has 0 disclosed suppliers and 4 disclosed customers in SEC filings.
SentenceOn October 7, 2020, Takeda and the Company entered into an Exclusive License and Co-Funding Agreement (the "Takeda License Agreement").
ARWR 10-Kaccession 0000879407-25-000029
—